Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Work In Process (2022 - 2025)

Historic Work In Process for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $1.9 million.

  • Jin Medical International's Work In Process rose 945.02% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 945.02%. This contributed to the annual value of $1.9 million for FY2025, which is 945.02% up from last year.
  • As of Q3 2025, Jin Medical International's Work In Process stood at $1.9 million, which was up 945.02% from $1.7 million recorded in Q3 2024.
  • Jin Medical International's 5-year Work In Process high stood at $1.9 million for Q3 2025, and its period low was $1.4 million during Q3 2022.
  • Its 4-year average for Work In Process is $1.7 million, with a median of $1.7 million in 2023.
  • As far as peak fluctuations go, Jin Medical International's Work In Process skyrocketed by 1534.64% in 2023, and later surged by 816.36% in 2024.
  • Over the past 4 years, Jin Medical International's Work In Process (Quarter) stood at $1.4 million in 2022, then increased by 15.35% to $1.6 million in 2023, then increased by 8.16% to $1.7 million in 2024, then rose by 9.45% to $1.9 million in 2025.
  • Its Work In Process was $1.9 million in Q3 2025, compared to $1.7 million in Q3 2024 and $1.6 million in Q3 2023.